The Impact of Absolute CD4 Count and Percentage Discordance on Pneumocystis Jirovecii Pneumonia Prophylaxis in HIV-Infected Patients

Current guidelines suggest that HIV-infected patients should receive chemoprophylaxis against Pneumocystis jirovecii pneumonia (PJP) if they have a cluster determinant 4 (CD4) count <200 cells/mm(3) or oropharyngeal candidiasis. Persons with CD4 percentage (CD4%) below 14% should also be consider...

Descripción completa

Detalles Bibliográficos
Autores principales: Anyimadu, Henry, Pingili, Chandra, Sivapalan, Vel, Hirsch-Moverman, Yael, Mannheimer, Sharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748489/
https://www.ncbi.nlm.nih.gov/pubmed/29534652
http://dx.doi.org/10.1177/2325958218759199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748489/
https://www.ncbi.nlm.nih.gov/pubmed/29534652
http://dx.doi.org/10.1177/2325958218759199

Ejemplares similares